Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag AstraZeneca's Imfinzi, combined with chemo, improves survival in early-stage gastric cancer, study shows.

flag AstraZeneca's drug Imfinzi, when combined with standard chemotherapy, has shown improved event-free survival in early-stage gastric cancer patients, according to the MATTERHORN Phase III trial. flag The drug also showed a strong trend for better overall survival. flag Gastric cancer is the fifth leading cause of cancer death globally, with nearly one million annual diagnoses. flag The treatment's safety profile aligns with known risks, and the results will be shared at a medical conference and with regulators.

8 Articles